{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T18:25:37Z","timestamp":1769279137028,"version":"3.49.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T00:00:00Z","timestamp":1736035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62371010"],"award-info":[{"award-number":["62371010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.tranon.2025.102279","type":"journal-article","created":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T16:44:11Z","timestamp":1739119451000},"page":"102279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Prognosis conferred by molecular features of appendix-derived Pseudomyxoma Peritonei"],"prefix":"10.1016","volume":"53","author":[{"given":"Ruiqing","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guojun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingjiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haipeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubiao","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanjun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3697-5267","authenticated-orcid":false,"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhidong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.tranon.2025.102279_bib0001","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejso.2007.04.002","article-title":"Appendiceal neoplasms and pseudomyxoma peritonei: a population based study","volume":"34","author":"Smeenk","year":"2008","journal-title":"Eur. J. Surgical Oncol.: J. Eur. Society of Surgical Oncol. British Association of Surgical Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102279_bib0002","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","article-title":"A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the peritoneal surface oncology group international (PSOGI) modified delphi process","volume":"40","author":"Carr","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"issue":"8","key":"10.1016\/j.tranon.2025.102279_bib0003","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/cncr.23825","article-title":"Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinoma","volume":"113","author":"Nance","year":"2008","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.tranon.2025.102279_bib0004","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.humpath.2009.01.010","article-title":"Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors","volume":"40","author":"Strosberg","year":"2009","journal-title":"Hum. Pathol."},{"issue":"5","key":"10.1016\/j.tranon.2025.102279_bib0005","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jtcvs.2005.12.057","article-title":"Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases","volume":"131","author":"Sun","year":"2006","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.tranon.2025.102279_bib0006","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1186\/1471-2407-14-663","article-title":"Histopathology-based prognostic score is independent prognostic factor of gastric carcinoma","volume":"14","author":"Zhu","year":"2014","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.tranon.2025.102279_bib0007","first-page":"281","article-title":"Report on the 9(th) international congress on peritoneal surface malignancies","volume":"11","author":"Li","year":"2014","journal-title":"Cancer Biol. & Med."},{"issue":"3","key":"10.1016\/j.tranon.2025.102279_bib0008","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.soc.2018.02.011","article-title":"Peritoneal metastases from colorectal cancer: treatment principles and perspectives","volume":"27","author":"Go\u00e9r\u00e9","year":"2018","journal-title":"Surg. Oncol. Clin. N. Am."},{"issue":"4","key":"10.1016\/j.tranon.2025.102279_bib0009","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/PPO.0000000000000135","article-title":"Targeted therapy for cancer in the genomic era","volume":"21","author":"Afghahi","year":"2015","journal-title":"Cancer J. (Sudbury, Mass)"},{"issue":"8","key":"10.1016\/j.tranon.2025.102279_bib0010","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.tranon.2025.102279_bib0011","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s10147-011-0323-2","article-title":"IDH1\/2 gene status defines the prognosis and molecular profiles in patients with grade III gliomas","volume":"17","author":"Shibahara","year":"2012","journal-title":"Int. J. Clin. Oncol."},{"issue":"29","key":"10.1016\/j.tranon.2025.102279_bib0012","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Le\u00f3n-Castillo","year":"2020","journal-title":"J. Clin. Oncol.: Official J. Am. Society of Clinical Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2025.102279_bib0013","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41575-019-0245-4","article-title":"Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer","volume":"17","author":"Buscail","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.tranon.2025.102279_bib0014","doi-asserted-by":"crossref","first-page":"E282","DOI":"10.1002\/ijc.29245","article-title":"Genomic profile of pseudomyxoma peritonei analyzed using next-generation sequencing and immunohistochemistry","volume":"136","author":"Nummela","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.tranon.2025.102279_bib0015","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1093\/annonc\/mdw314","article-title":"Toward the molecular dissection of peritoneal pseudomyxoma","volume":"27","author":"Pietrantonio","year":"2016","journal-title":"Annals of Oncol.: Official J. Eur. Society Med. Oncol."},{"issue":"12","key":"10.1016\/j.tranon.2025.102279_bib0016","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/cam4.542","article-title":"Molecular profiles of high-grade and low-grade pseudomyxoma peritonei","volume":"4","author":"Noguchi","year":"2015","journal-title":"Cancer Med."},{"issue":"14","key":"10.1016\/j.tranon.2025.102279_bib0017","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.tranon.2025.102279_bib0018","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.tranon.2025.102279_bib0019","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.tranon.2025.102279_bib0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13059-016-0893-4","article-title":"DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution","volume":"17","author":"Rosenthal","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.tranon.2025.102279_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2020.102827","article-title":"Two main mutational processes operate in the absence of DNA mismatch repair","volume":"89","author":"N\u00e9meth","year":"2020","journal-title":"DNA Repair (Amst.)"},{"issue":"22","key":"10.1016\/j.tranon.2025.102279_bib0022","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1093\/bioinformatics\/btv408","article-title":"SomaticSignatures: inferring mutational signatures from single-nucleotide variants","volume":"31","author":"Gehring","year":"2015","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.tranon.2025.102279_bib0023","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.celrep.2012.12.008","article-title":"Deciphering signatures of mutational processes operative in human cancer","volume":"3","author":"Alexandrov","year":"2013","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.tranon.2025.102279_bib0024","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1002\/ijc.33460","article-title":"The mutational landscape and prognostic indicators of pseudomyxoma peritonei originating from the ovary","volume":"148","author":"Wang","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.tranon.2025.102279_bib0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/em.22087","article-title":"Mechanisms of DNA damage, repair, and mutagenesis","volume":"58","author":"Chatterjee","year":"2017","journal-title":"Environ. Mol. Mutagen."},{"issue":"8","key":"10.1016\/j.tranon.2025.102279_bib0026","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/annonc\/mdw142","article-title":"BRCA somatic mutations and epigenetic BRCA modifications in serous ovarian cancer","volume":"27","author":"Moschetta","year":"2016","journal-title":"Annals of Oncol.: Official J. Eur. Society for Med. Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2025.102279_bib0027","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.semcancer.2010.10.003","article-title":"Mutator phenotypes due to DNA replication infidelity","volume":"20","author":"Arana","year":"2010","journal-title":"Semin. Cancer Biol."},{"issue":"10","key":"10.1016\/j.tranon.2025.102279_bib0028","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1200\/JCO.22.02462","article-title":"Mismatch repair and microsatellite instability testing for immune checkpoint inhibitor therapy: ASCO endorsement of college of american pathologists guideline","volume":"41","author":"Vikas","year":"2023","journal-title":"J. Clin. Oncol.: Official J. Am. Society of Clin. Oncol."},{"key":"10.1016\/j.tranon.2025.102279_bib0029","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1101\/sqb.2009.74.027","article-title":"Evolving views of DNA replication (in)fidelity","volume":"74","author":"Kunkel","year":"2009","journal-title":"Cold Spring Harbor Symp. Quant. Biol."},{"issue":"suppl 1","key":"10.1016\/j.tranon.2025.102279_bib0030","doi-asserted-by":"crossref","first-page":"e450s","DOI":"10.6061\/clinics\/2018\/e450s","article-title":"Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management","volume":"73","author":"da Cunha","year":"2018","journal-title":"Clinics (Sao Paulo, Brazil)"},{"issue":"6312","key":"10.1016\/j.tranon.2025.102279_bib0031","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1126\/science.aag0299","article-title":"Mutational signatures associated with tobacco smoking in human cancer","volume":"354","author":"Alexandrov","year":"2016","journal-title":"Science"},{"issue":"7793","key":"10.1016\/j.tranon.2025.102279_bib0032","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.tranon.2025.102279_bib0033","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jtho.2022.11.030","article-title":"Tobacco smoking-related mutational signatures in classifying smoking-associated and nonsmoking-associated NSCLC","volume":"18","author":"Ernst","year":"2023","journal-title":"J. Thoracic Oncol.: Official Publication of the Int. Associat. Study of Lung Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2025.102279_bib0034","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10555-023-10088-0","article-title":"The genetic profile and molecular subtypes of human pseudomyxoma peritonei and appendiceal mucinous neoplasms: a systematic review","volume":"42","author":"Murage","year":"2023","journal-title":"Cancer Metastasis Rev."},{"issue":"9","key":"10.1016\/j.tranon.2025.102279_bib0035","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/01.MP.0000026617.52466.9F","article-title":"MUC2 is a molecular marker for pseudomyxoma peritonei","volume":"15","author":"O'Connell","year":"2002","journal-title":"Modern Pathol.: An Official J. United States and Canadian Acad. Pathol., Inc"},{"issue":"5","key":"10.1016\/j.tranon.2025.102279_bib0036","doi-asserted-by":"crossref","first-page":"G949","DOI":"10.1152\/ajpgi.00142.2005","article-title":"Vasoactive intestinal peptide upregulates MUC2 intestinal mucin via CREB\/ATF1","volume":"289","author":"Hokari","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"9","key":"10.1016\/j.tranon.2025.102279_bib0037","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00432-020-03321-8","article-title":"The biological basis and function of GNAS mutation in pseudomyxoma peritonei: a review","volume":"146","author":"Lin","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102279_bib0038","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/humu.21377","article-title":"Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders","volume":"32","author":"Gremer","year":"2011","journal-title":"Hum. Mutat."},{"issue":"44","key":"10.1016\/j.tranon.2025.102279_bib0039","doi-asserted-by":"crossref","first-page":"6942","DOI":"10.1038\/sj.onc.1206749","article-title":"BRAF and KRAS mutations in stomach cancer","volume":"22","author":"Lee","year":"2003","journal-title":"Oncogene"},{"issue":"22","key":"10.1016\/j.tranon.2025.102279_bib0040","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1242\/dev.030338","article-title":"The regulation of TGFbeta signal transduction","volume":"136","author":"Moustakas","year":"2009","journal-title":"Development"},{"issue":"1","key":"10.1016\/j.tranon.2025.102279_bib0041","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/CCO.0b013e32835b6371","article-title":"TGF-\u03b2 signaling and epithelial-mesenchymal transition in cancer progression","volume":"25","author":"Katsuno","year":"2013","journal-title":"Curr. Opin. Oncol."},{"issue":"7693","key":"10.1016\/j.tranon.2025.102279_bib0042","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.tranon.2025.102279_bib0043","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.molcel.2018.07.034","article-title":"Non-canonical activation of the DNA sensing adaptor STING by ATM and IFI16 Mediates NF-\u03baB signaling after nuclear DNA damage","volume":"71","author":"Dunphy","year":"2018","journal-title":"Mol. Cell"},{"issue":"8","key":"10.1016\/j.tranon.2025.102279_bib0044","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41568-020-0262-1","article-title":"p53: 800 million years of evolution and 40 years of discovery","volume":"20","author":"Levine","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2025.102279_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188556","article-title":"Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting","volume":"1876","author":"Hern\u00e1ndez Borrero","year":"2021","journal-title":"Biochimica et Biophysica acta Reviews on Cancer"},{"issue":"5383","key":"10.1016\/j.tranon.2025.102279_bib0046","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1126\/science.281.5383.1674","article-title":"Enhanced phosphorylation of p53 by ATM in response to DNA damage","volume":"281","author":"Banin","year":"1998","journal-title":"Science"},{"issue":"5383","key":"10.1016\/j.tranon.2025.102279_bib0047","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1126\/science.281.5383.1677","article-title":"Activation of the ATM kinase by ionizing radiation and phosphorylation of p53","volume":"281","author":"Canman","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.tranon.2025.102279_bib0048","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.semcancer.2018.03.005","article-title":"Ras and Rap1: A tale of two GTPases","volume":"54","author":"Shah","year":"2019","journal-title":"Semin. Cancer Biol."},{"issue":"7","key":"10.1016\/j.tranon.2025.102279_bib0049","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.molimm.2006.07.292","article-title":"Flagellin and lipopolysaccharide stimulate the MEK-ERK signaling pathway in chicken heterophils through differential activation of the small GTPases","volume":"44","author":"Kogut","year":"2007","journal-title":"Ras and Rap1. Mol. Immunol."},{"issue":"1-2","key":"10.1016\/j.tranon.2025.102279_bib0050","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/ans.18041","article-title":"Preoperative systemic chemotherapy does not benefit for appendiceal pseudomyxoma peritonei","volume":"93","author":"Ma","year":"2023","journal-title":"ANZ J. Surg."},{"issue":"20","key":"10.1016\/j.tranon.2025.102279_bib0051","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J. Clin. Oncol.: Official J. Am. Society of Clin. Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2025.102279_bib0052","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026062","article-title":"Tumor-suppressor functions of the TP53 pathway","volume":"6","author":"Aubrey","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.tranon.2025.102279_bib0053","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.humpath.2018.11.011","article-title":"Heterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms","volume":"85","author":"Zhu","year":"2019","journal-title":"Hum. Pathol."},{"issue":"10","key":"10.1016\/j.tranon.2025.102279_bib0054","article-title":"Mucin1 and mucin16: therapeutic targets for cancer therapy","volume":"14","author":"Lee","year":"2021","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"8","key":"10.1016\/j.tranon.2025.102279_bib0055","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/14728222.2018.1498845","article-title":"MUC16 as a novel target for cancer therapy","volume":"22","author":"Aithal","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.tranon.2025.102279_bib0056","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1073820","article-title":"MUC16 and TP53 family co-regulate tumor-stromal heterogeneity in pancreatic adenocarcinoma","volume":"13","author":"Chirravuri-Venkata","year":"2023","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.tranon.2025.102279_bib0057","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.humpath.2014.04.018","article-title":"GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survival","volume":"45","author":"Singhi","year":"2014","journal-title":"Hum. Pathol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325000105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325000105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:35:16Z","timestamp":1762562116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523325000105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":57,"alternative-id":["S1936523325000105"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102279","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognosis conferred by molecular features of appendix-derived Pseudomyxoma Peritonei","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102279","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102279"}}